172 related articles for article (PubMed ID: 29065539)
21. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.
Jandourek O; Tauchman M; Paterova P; Konecna K; Navratilova L; Kubicek V; Holas O; Zitko J; Dolezal M
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157178
[TBL] [Abstract][Full Text] [Related]
22. Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.
Kucerova-Chlupacova M; Kunes J; Buchta V; Vejsova M; Opletalova V
Molecules; 2015 Jan; 20(1):1104-17. PubMed ID: 25587786
[TBL] [Abstract][Full Text] [Related]
23. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, biological evaluation against Mycobacterium tuberculosis and docking studies.
Gangarapu NR; Ranganatham A; Reddy EK; Yellappa S; Chandrasekhar KB
Arch Pharm (Weinheim); 2020 Jul; 353(7):e1900368. PubMed ID: 32399980
[TBL] [Abstract][Full Text] [Related]
24. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
Das R; Mehta DK
Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.
Zitko J; Paterová P; Kubíček V; Mandíková J; Trejtnar F; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2013 Jan; 23(2):476-9. PubMed ID: 23237840
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
[TBL] [Abstract][Full Text] [Related]
28. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
29. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.
Wächter GA; Davis MC; Martin AR; Franzblau SG
J Med Chem; 1998 Jun; 41(13):2436-8. PubMed ID: 9632376
[TBL] [Abstract][Full Text] [Related]
30. In vitro antimycobacterial activities of pyrazinamide analogs.
Yamamoto S; Toida I; Watanabe N; Ura T
Antimicrob Agents Chemother; 1995 Sep; 39(9):2088-91. PubMed ID: 8540721
[TBL] [Abstract][Full Text] [Related]
31. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
32. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
Bonde CG; Peepliwal A; Gaikwad NJ
Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
[TBL] [Abstract][Full Text] [Related]
34. Lipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare.
Liu ZZ; Guo XD; Straub LE; Erdos G; Prankerd RJ; Gonzalez-Rothi RJ; Schreier H
Drug Des Discov; 1991 Nov; 8(1):57-67. PubMed ID: 1810412
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivatives.
Jampilek J; Dolezal M; Buchta V
Med Chem; 2007 May; 3(3):277-80. PubMed ID: 17504199
[TBL] [Abstract][Full Text] [Related]
36. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
[TBL] [Abstract][Full Text] [Related]
37. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
38. Studies on pyrazine derivatives. XXXII. Synthesis and tuberculostatic activity of acetylpyrazine thiosemicarbazone derivatives.
Milczarska B; Foks H; Trapkowski Z; Milzyńska-Kołaczek A; Janowiec M; Zwolska Z; Andrzejczyk Z
Acta Pol Pharm; 1998; 55(4):289-95. PubMed ID: 9821394
[TBL] [Abstract][Full Text] [Related]
39. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of Leubethanol derivatives and evaluation against Mycobacterium tuberculosis.
Perez-Meseguer J; Del Olmo E; Alanis-Garza B; Escarcena R; Garza-González E; Salazar-Aranda R; Feliciano AS; de Torres NW
Bioorg Med Chem; 2012 Jul; 20(13):4155-63. PubMed ID: 22626551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]